» Authors » Parviz M Pour

Parviz M Pour

Explore the profile of Parviz M Pour including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 333
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Iki K, Pour P
J Histochem Cytochem . 2006 Sep; 55(2):111-8. PMID: 16982850
There is a lack of agreement on the distribution of islet amyloid polypeptide (IAPP) in the pancreases of healthy and diabetic subjects. Therefore, a detailed morphometrical and immunohistochemical study was...
12.
Iki K, Pour P
Pancreatology . 2006 Jul; 6(4):406-13. PMID: 16809941
Background: Oct4 has been shown to present a stem cell marker that is expressed in embryonic cells and in germ cell tumors. Recently, its expression in a few human tissues...
13.
Yalniz M, Pour P
Pancreas . 2005 Jul; 31(2):108-18. PMID: 16024996
A vast number of studies indicate the presence of stem/progenitor cells virtually in all tissues in adult organs, particularly in bone marrow. Recent studies, however, cast doubt about the existence...
14.
Nozawa F, Pour P
Pancreatology . 2005 Jun; 5(4-5):410-5. PMID: 15985765
Background: Hepatocellular differentiation of pancreatic cells has been observed under certain conditions in several species, including humans. Their cell of origin and biology has remained controversial. Generally, these lesions have...
15.
El-Metwally T, Hussein M, Pour P, Kuszynski C, Adrian T
Cancer Biol Ther . 2005 Jun; 4(5):602-11. PMID: 15970678
Background: Our previous investigations showed that retinoids, at specific concentrations, can inhibit cell proliferation. In this investigation, we hypothesize that high concentrations of retinoids can induce phenotypic changes (differentiation) and...
16.
El-Metwally T, Hussein M, Pour P, Kuszynski C, Adrian T
Cancer Biol Ther . 2005 May; 4(4):474-83. PMID: 15908778
Background: The anticancer ability of natural retinoids on pancreatic adenocarcinoma, an aggressive tumor, is still controversial. This investigation tested the hypothesis that all-trans retinoic acid can inhibit proliferation and induce...
17.
Standop J, Andrianifahanana M, Moniaux N, Schneider M, Ulrich A, Brand R, et al.
Pancreatology . 2005 Mar; 5(1):44-58. PMID: 15775699
Background/aims: The overexpression of ErbB2 in pancreatic cancer has been reported with a varying incidence ranging between 1 and 80%. Our routine examination, however, revealed a consistently strong immunoreactivity of...
18.
Standop J, Schneider M, Ulrich A, Mathiak G, Brand R, Buechler M, et al.
Oncol Rep . 2004 Nov; 12(6):1309-15. PMID: 15547756
Histological differentiation between chronic pancreatitis and pancreatic cancer, especially in biopsy material, remains challenging and the frequent association of 'secondary' chronic pancreatitis (due to ductal obstruction) with pancreatic cancer causes...
19.
Nozawa F, Itami A, Saruc M, Kim M, Standop J, Picha K, et al.
Pancreas . 2004 Jun; 29(1):45-52. PMID: 15211111
Objectives: Our previous studies have shown that, contrary to many other human pancreatic adenocarcinoma cell lines, AsPC1 cells are resistant to the apoptotic effect of the tumor necrosis factor-related apoptosis-inducing...
20.
Saruc M, Standop S, Standop J, Nozawa F, Itami A, Pandey K, et al.
Pancreas . 2004 Apr; 28(4):401-12. PMID: 15097858
Objectives: The disappointing current therapeutic approaches for pancreatic cancer (PC) represent an urgent need for the development of novel methods to control the disease. Based on a recent report on...